TREATING AMELOBLASTOMA WITH INFERIOR BORDER OF MANDIBLE AS A GUIDE: A CASE SERIES
Article Sidebar
Main Article Content
Abstract
ABSTRACT
Ameloblastoma, is the commonest odontogenic tumor. Solid ameloblastoma is the most common aggressive type with highest recurrence rate.
Treatment varies from enucleation, curettage to resection of the jaw
and depends upon clinical behavior, age of patient and site. We present
a series of five cases of Ameloblastoma in young patients, managed from July 2012 to June 2013, by using inferior border as a guide to reduce morbidity. Patients with less than 35 years of age and having intact inferior border of mandible underwent enucleation while jaw resection was done in patients with absorbed inferior border of mandible.Fourpatients underwent enucleation with recurrence in one case while one patient underwent hemimandibulectomy with no recurrence. All fivepatients, still being followed up, are tumor free since the treatment up to two years post-treatment.
KEY WORDS: Ameloblastoma (MeSH), Inferior Border of Mandible
(Non-MeSH), Mandibular Neoplasms (MeSH), Neoplasm Recurrence
Local (MeSH), Case Series (Non-MeSH).
Article Details
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Shafer, Hine, Levy. Shafer`s Text book of Oral Pathology (edition 5). Churchill Livingstone; 2005.p.357-432.
Dolan EA, Angelillo JC, Georgiade NG. Recurrent ameloblastoma in autogenous rib graft. Oral Surg., 1981; 51:357-360.
Muller H, Slootweg PJ. The growth characteristics of multilocular ameloblastoma. J. Maxillofac Surg., 1985; 13:224-230.
Gümgüm S, Hoşgören B.Clinical and radiologic behaviour of ameloblastoma in 4 cases. J Can Dent Assoc. 2005 Jul-Aug; 71(7):481-4.
Amzerin M et al.Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature J Med Case Rep. 2011 Oct 3; 5:491. doi: 10.1186/1752-1947-5-491.
Nagai N, Takeshita N, Nagatsuka H, Inoue M, Nishijima K, Nojima T, Yamasaki M, Hoh C. Ameloblastic carcinoma: case report and review.J Oral Pathol Med. 1991 Oct;20(9):460-3.
J.A. Mallick,S.A. Ali Ameloblastoma - Management and Review of Literature.JPMA October, 2002;80, No.10.
Ferretti C, Polakow R, Coleman H. Recurrent ameloblastoma: reportof 2 cases. J Oral Maxillofac Surg 2000; 58(7):800–4.
Kim SG, Jang HS. Ameloblastoma: a clinical, radiographic and histopathologic analysis of 71 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91(6):649–53.
Nakamura N, Higuchi Y, Mitsuyasu T, Sandra F, Ohishi M.Comparison of long-term results between different approaches to ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93(1):13–20.
Dandriyal R., Gupta A., Pant s., and Baweja H.H. “Surgical management of ameloblastoma: Conservative or radical approach.Natl J Maxillofac Surg. 2011 Jan-Jun; 2(1): 22–27.
Kumar K., K. R., George GB, Padiyath S., Rupak S. “Mural Unicystic Ameloblastoma Crossing the Midline: A Rare Case Report.” Int. J. Odontostomat., 6(1):97-103, 2012.
Cardesa A. , Slootweg P J. “ Pathology of the Head and Neck.” In: Slootweg PJ. Maxillofacial Skeleton and Teeth.Springer-Verlag Berlin Heidelberg: 2006.